Aclaris Therapeutics, Inc. (ACRS)
NASDAQ: ACRS · Real-Time Price · USD
2.720
-0.050 (-1.81%)
At close: Dec 20, 2024, 4:00 PM
3.000
+0.280 (10.29%)
After-hours: Dec 20, 2024, 7:05 PM EST
Aclaris Therapeutics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for ACRS stock have an average target of 8.75, with a low estimate of 7.00 and a high estimate of 13. The average target predicts an increase of 221.69% from the current stock price of 2.72.
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 19, 2024.
Analyst Ratings
The average analyst rating for ACRS stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 2 | 2 |
| Hold | 5 | 5 | 5 | 5 | 2 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Leerink Partners | Leerink Partners | Hold → Buy Upgrades $2 → $7 | Hold → Buy | Upgrades | $2 → $7 | +157.35% | Nov 19, 2024 |
| Jefferies | Jefferies | Hold → Strong Buy Upgrades $2 → $7 | Hold → Strong Buy | Upgrades | $2 → $7 | +157.35% | Nov 19, 2024 |
| BTIG | BTIG | Hold → Strong Buy Upgrades $8 | Hold → Strong Buy | Upgrades | $8 | +194.12% | Nov 19, 2024 |
| Piper Sandler | Piper Sandler | Hold → Buy Upgrades $3 → $13 | Hold → Buy | Upgrades | $3 → $13 | +377.94% | Nov 18, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Sep 17, 2024 |
Financial Forecast
Revenue This Year
11.68M
from 31.25M
Decreased by -62.63%
Revenue Next Year
9.07M
from 11.68M
Decreased by -22.32%
EPS This Year
-0.70
from -1.27
EPS Next Year
-0.46
from -0.70
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 14.6M | 20.9M | 22.9M | |||
| Avg | 11.7M | 9.1M | 9.6M | |||
| Low | 9.9M | 2.5M | 2.5M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -53.3% | 78.9% | 152.3% | |||
| Avg | -62.6% | -22.3% | 5.6% | |||
| Low | -68.2% | -78.4% | -72.2% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -0.33 | -0.16 | -0.50 | |||
| Avg | -0.70 | -0.46 | -0.59 | |||
| Low | -1.11 | -0.54 | -0.68 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.